Scarica l'app Stockscreener
74.66
0.12%
0.09
Dopo l'orario di chiusura:
74.66
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$74.57
Aprire:
$74.31
Volume 24 ore:
3.31M
Relative Volume:
0.79
Capitalizzazione di mercato:
$43.83B
Reddito:
$5.69B
Utile/perdita netta:
$1.41B
Rapporto P/E:
10.74
EPS:
6.95
Flusso di cassa netto:
$577.90M
1 W Prestazione:
-0.72%
1M Prestazione:
-8.76%
6M Prestazione:
+4.64%
1 anno Prestazione:
+12.56%
Intervallo 1D:
$74.02
$75.30
Intervallo di 1 settimana:
$73.05
$75.92
Portata 52W:
$64.00
$83.00
Edwards Lifesciences Corp Stock (EW) Company Profile
Nome
Edwards Lifesciences Corp
Settore
Industria
Telefono
(949) 250-2500
Indirizzo
ONE EDWARDS WAY, IRVINE, CA
Confronta EW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
74.66 | 43.78B | 5.69B | 1.41B | 577.90M | 6.95 |
|
ABT
Abbott Laboratories
|
133.89 | 236.51B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
98.06 | 144.75B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
371.22 | 142.80B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.74 | 121.80B | 34.20B | 4.69B | 5.30B | 3.63 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-29 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-04-24 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Stifel | Hold → Buy |
| 2025-01-16 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-11 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-09-18 | Downgrade | Jefferies | Buy → Hold |
| 2024-07-31 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-07-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | Downgrade | TD Cowen | Buy → Hold |
| 2024-07-25 | Downgrade | Truist | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-05-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-03-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-02-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2023-11-28 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-03-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | Downgrade | Bernstein | Outperform → Underperform |
| 2023-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | Downgrade | Stifel | Buy → Hold |
| 2022-10-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-10-26 | Iniziato | Mizuho | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-29 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-27 | Reiterato | Citigroup | Buy |
| 2022-01-27 | Reiterato | Evercore ISI | Outperform |
| 2022-01-27 | Reiterato | Raymond James | Outperform |
| 2022-01-27 | Reiterato | Stifel | Buy |
| 2022-01-27 | Reiterato | UBS | Neutral |
| 2021-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-12-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | Reiterato | Canaccord Genuity | Buy |
| 2021-07-30 | Reiterato | Deutsche Bank | Hold |
| 2021-07-30 | Reiterato | Jefferies | Buy |
| 2021-07-30 | Reiterato | Morgan Stanley | Overweight |
| 2021-07-30 | Reiterato | Oppenheimer | Outperform |
| 2021-07-30 | Reiterato | Stifel | Buy |
| 2021-07-30 | Reiterato | UBS | Neutral |
| 2021-07-30 | Reiterato | Wells Fargo | Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Neutral |
| 2021-04-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-11 | Reiterato | Canaccord Genuity | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Underperform |
| 2020-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Neutral |
| 2020-01-10 | Iniziato | Oppenheimer | Outperform |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-10-24 | Reiterato | Canaccord Genuity | Buy |
| 2019-09-23 | Iniziato | Piper Jaffray | Overweight |
| 2019-07-24 | Reiterato | BofA/Merrill | Buy |
| 2019-03-18 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Hold |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-10-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | Downgrade | Guggenheim | Buy → Neutral |
Mostra tutto
Edwards Lifesciences Corp Borsa (EW) Ultime notizie
CHICAGO TRUST Co NA Grows Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE:EW) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Swedbank AB - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by BDF Gestion - MarketBeat
Diversified Trust Co Buys 4,454 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
MassMutual Private Wealth & Trust FSB Decreases Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
The Returns On Capital At Edwards Lifesciences (NYSE:EW) Don't Inspire Confidence - Yahoo Finance
Stifel Lowers Price Target for Edwards Lifesciences (EW) to $85 - GuruFocus
Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $95, Maintains Buy Rating - MarketScreener
Edwards Lifesciences price target lowered to $85 by Stifel on TAVR data concerns - Investing.com
NorthCrest Asset Manangement LLC Takes $330,000 Position in Edwards Lifesciences Corporation $EW - MarketBeat
Wealth Enhancement Advisory Services LLC Buys 86,186 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Purchased by Czech National Bank - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Sees Significant Increase in Short Interest - MarketBeat
Performance Recap: Does Energy Fuels Inc. stock reflect fundamentalsJuly 2025 Institutional & Community Verified Watchlist Alerts - khodrobank.com
Aug PreEarnings: How sensitive is Edwards Lifesciences Corporation to inflation2025 Market Outlook & Weekly Stock Breakout Alerts - خودرو بانک
Edwards Lifesciences Corporation $EW Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Aug Movers: Whats the outlook for Edwards Lifesciences Corporations sectorEntry Point & Growth Oriented Trade Recommendations - khodrobank.com
E. Ohman J or Asset Management AB Acquires New Shares in Edwards Lifesciences Corporation $EW - MarketBeat
Seilern Investment Management Ltd Has $96.89 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (EW): A Bull Case Theory - Yahoo Finance
Capital Asset Advisory Services LLC Acquires Shares of 5,853 Edwards Lifesciences Corporation $EW - MarketBeat
Neville Rodie & Shaw Inc. Sells 3,522 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Treasury Yields: Will Edwards Lifesciences Corporation outperform its industry peersLong Setup & Fast Moving Trade Plans - خودرو بانک
Analysis Recap: Whats the outlook for Edwards Lifesciences Corporations sectorGold Moves & Real-Time Volume Triggers - khodrobank.com
Aug Rallies: What makes WLDSW stock attractive today2025 Breakouts & Breakdowns & Weekly Return Optimization Alerts - khodrobank.com
Swedbank AB Decreases Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE:EW) Rating Lowered to "Buy" at Wall Street Zen - MarketBeat
Acadian Asset Management LLC Grows Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Bowman & Co S.C. Trims Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Intech Investment Management LLC Cuts Position in Edwards Lifesciences Corporation $EW - MarketBeat
Militia Capital Partners LP Sells 60,000 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Stake Raised by Howe & Rusling Inc. - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Edwards Lifesciences Stock: Analyst Estimates & Ratings - MSN
NewEdge Advisors LLC Has $2.39 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Trading Recap: Is Edwards Lifesciences Corporations growth already priced inJuly 2025 Weekly Recap & Weekly Watchlist for Hot Stocks - خودرو بانک
Pacific Capital Partners Ltd Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Glenview Trust co Decreases Position in Edwards Lifesciences Corporation $EW - MarketBeat
Exit Recap: Can Edwards Lifesciences Corporation generate free cash flowWeekly Gains Summary & Low Drawdown Momentum Trade Ideas - خودرو بانک
Edwards Lifesciences Corporation $EW Stake Boosted by Focus Partners Wealth - MarketBeat
Relative Strength Alert For Edwards Lifesciences - Nasdaq
Downgrade Watch: Whats the outlook for Edwards Lifesciences Corporations sectorFed Meeting & Short-Term Swing Trade Alerts - خودرو بانک
Institutional investors in Edwards Lifesciences Corporation (NYSE:EW) see US$1.5b decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance
Jacobs & Co. CA Sells 7,261 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
24,437 Shares in Edwards Lifesciences Corporation $EW Purchased by AG2R LA Mondiale Gestion D Actifs - MarketBeat
Voya Investment Management LLC Lowers Position in Edwards Lifesciences Corporation $EW - MarketBeat
14,705 Shares in Edwards Lifesciences Corporation $EW Bought by Voleon Capital Management LP - MarketBeat
Caxton Associates LLP Invests $370,000 in Edwards Lifesciences Corporation $EW - MarketBeat
Strs Ohio Makes New $9.49 Million Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp Azioni (EW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):